Showing results (81-90 of 124) with videos related to

Sort By:
Pageof 13
EXCLI Journal|September 30, 2015
Nesfatin-1: role as possible new anti-obesity treatmentCarmine Finelli, Giuseppe Martelli, Rocco Rossano, et al.
Journal of Gastroenterology|February 27, 2007
Mental status impairment in patients with West Haven grade zero hepatic encephalopathy: the role of HCV infectionVincenzo Citro, Graziella Milan, Francesca Saveria Tripodi, et al.
Journal of Translational Medicine|August 6, 2014
Is serum Interleukin-17 associated with early atherosclerosis in obese patients?Giovanni Tarantino, Susan Costantini, Carmine Finelli, et al.
Arthritis Research & Therapy|October 6, 2012
Hepatic steatosis, carotid plaques and achieving MDA in psoriatic arthritis patients starting TNF-α blockers treatment: a prospective studyMatteo Nicola Dario Di Minno, Rosario Peluso, Salvatore Iervolino, et al.
World Journal of Gastroenterology|April 8, 2011
Is spleen circulation impaired in systemic sclerosis and what is the role of liver fibrosis?Giovanni Tarantino, Angelo Spanò, Gabriella Loi, et al.
BMC Gastroenterology|November 26, 2009
What are the implications of the spontaneous spleno-renal shunts in liver cirrhosis?Giovanni Tarantino, Vincenzo Citro, Paolo Conca, et al.
Oxidative Medicine and Cellular Longevity|July 15, 2017
Adherence to the Mediterranean Diet and Circulating Levels of Sirtuin 4 in Obese Patients: A Novel AssociationLuigi Barrea, Giovanni Tarantino, Carolina Di Somma, et al.
Fundamental & Clinical Pharmacology|August 7, 2009
EC-MPS permits lower gastrointestinal symptom burden despite higher MPA exposure in patients with severe MMF-related gastrointestinal side-effectsMassimo Sabbatini, Domenico Capone, Riccardo Gallo, et al.
European Journal of Gastroenterology & Hepatology|March 26, 2009
Could inflammatory markers help diagnose nonalcoholic steatohepatitis?Giovanni Tarantino, Paolo Conca, Fabrizio Pasanisi, et al.
Pageof 13